Research and development of novel embolization materials and study on their feasibility of preventing T2EL after EVAR abdominal aortic aneurysm - Summary - MDSpire

Research and development of novel embolization materials and study on their feasibility of preventing T2EL after EVAR abdominal aortic aneurysm

  • By

  • E. Erdemutu

  • Boru Huang

  • Liqiang Hu

  • Shaohong Yin

  • Ying Lan

  • Chongbin Zhou

  • Xiangchen Dai

  • June 1, 2026

Share

Objective:

Emphasize the clinical significance of preventing T2EL.

Key Findings:
  • Include the significance of findings in relation to existing treatments.
Interpretation:

Elaborate on implications for clinical practice.

Limitations:
  • Add a section discussing potential weaknesses or areas for further research.
Conclusion:

TCC is a promising embolic agent for preventing T2EL after EVAR.

Original Source(s)

Research and development of novel embolization materials and study on their feasibility of preventing T2EL after EVAR abdominal aortic aneurysm

  • by E. Erdemutu, Boru Huang, Liqiang Hu, Shaohong Yin, Ying Lan, Chongbin Zhou, Xiangchen Dai

  • June 1, 2026

Related Content

Perioperative anesthetic considerations and outcomes in Crouzon syndrome: a retrospective analysis of Le Fort III advancement surgery

CAA Use Tied to Higher Arthroplasty Risk

In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

A nurse-led bundled care intervention for preventing deep vein thrombosis in immobilized neurosurgical patients: a quasi-experimental study